Color Health is betting its future on providing cancer care, not just testing. Burlingame, California-based Color got its ...
A new study out of Harvard Medical School and West Virginia University suggests that fighting prescription drug patents ...
March means the NCAA Tournament in the sports world, and Exact Sciences is hoping to inspire middle-aged fans to get screened ...
Just as in­sulin man­u­fac­tur­ers were pres­sured in­to cap­ping month­ly out-of-pock­et costs, in­haler man­u­fac­tur­ers ...
The FDA ap­proved a gene ther­a­py known as Len­meldy for ear­ly-on­set metachro­mat­ic leukody­s­tro­phy, or MLD, a rare and ...
Re­gen­eron on Mon­day suc­cess­ful­ly flipped a low­er court’s de­ci­sion in a hot­ly-con­test­ed case against No­var­tis ...
WuXi AppTec’s an­nu­al re­port on Mon­day re­veals what’s at stake for the Shang­hai-based ser­vice provider if the ...
This week, we’re launch­ing Post-Hoc. Writ­ten by our re­porters and ed­i­tors, Post-Hoc is a week­ly(ish) piece of analy­sis ...
The bio­phar­ma­ceu­ti­cal in­dus­try is a fas­ci­nat­ing and cycli­cal ecosys­tem. De­spite the stiff eco­nom­ic head­winds ...
Clinical-stage biotech Contineum Therapeutics, which until recently went by the name Pipeline Therapeutics, on Friday ...
In a win for Arkansas and the federal drug discount program known as 340B, a federal appeals court said the state can block ...
Former Theseus executives are now steering the ship at Ben Auspitz and Alexis Borisy's IDRx as the biotech looks to continue ...